The majority (about 70–80%) of uveal melanoma addressed at the College Healthcare facility Essen receive episcleral plaque therapy devoid of histological verification. For that reason we didn't include things like a reference pathologist who reviews the diagnostic certainty of the conditions. Experiences from our preceding scenario-Management sci… Read More